Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Elizabeth Kim

Plastic and Reconstructive Surgery Beverly Hills, CA Medical Doctor

NPI 1346306214 CMS profile 243008

436 N Bedford Dr, 103, Beverly Hills, CA 90210

Open in the dashboard

General payments

$26,640

96 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Elizabeth Kim of Beverly Hills, CA is reported in the CMS Open Payments database as having received $26,640 across 96 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $748 1
2023 General $247 10
2022 General $8,439 27
2021 General $4,012 18
2020 General $12,539 23
2019 General $654 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Kim
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Elizabeth Kim were reported at $0. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Elizabeth Kim Plastic and Reconstructive Surgery median Middle half National median
2019 $654 $335 $121–$1,264 $163
2020 $12,539 $162 $57–$417 $114
2021 $4,012 $245 $89–$735 $132
2022 $8,439 $325 $120–$932 $149
2023 $247 $343 $129–$999 $160
2024 $748 $390 $141–$1,085 $164
2025 $0 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Allergan Inc. $20,854 78 payments
  2. RTI Surgical, Inc $2,500 2 payments
  3. Surgical Innovation Associates, Inc. $2,126 2 payments
  4. Integra LifeSciences Corporation $748 1 payment
  5. AbbVie, Inc. $247 10 payments
  6. Solta Medical, a division of Bausch Health US, LLC $104 1 payment
  7. Sientra, Inc. $60 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $14,051 13 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,182 7 payments
  3. Food and Beverage $2,007 71 payments
  4. Long term medical supply or device loan $1,374 2 payments
  5. Education $25 3 payments
Products named General payments · program years 2019–2024
  1. NATRELLE $11,713 31 payments
  2. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $8,528 33 payments
  3. CORTIVA ALLOGRAFT DERMIS $2,500 2 payments
  4. DuraSorb Monofilament Mesh Mesh, Surgical, Polymeric $2,126 2 payments
  5. STRATTICE $1,504 3 payments
  6. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $900 1 payment
  7. DuraSorb Monofilament Mesh SIA/Surgical Innovation Associates $748 1 payment
  8. ARTIA RECONSTRUCTIVE TISSUE MATRIX $248 1 payment
  9. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $176 5 payments
  10. BOTOX $137 12 payments
  11. Other $113 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$25,249

Medicare's payments for the services billed

Medicare patients

52

Average age 71

Services billed

114

52 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
Arthritis 54%
High blood pressure 40%
Osteoporosis 38%
Depression 27%
Ischemic heart disease 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

96 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record